← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
OXLCO
Oxford Lane Capital Corp.
Valuation N/A
Unknown
Price$23.78
Model IV—
P/IV—
Limited data — see page
OXLCP
Oxford Lane Capital Corp.
Valuation N/A
Unknown
Price$25.01
Model IV—
P/IV—
Limited data — see page
OXLCZ
Oxford Lane Capital Corp.
Valuation N/A
Unknown
Price$25.15
Model IV—
P/IV—
Limited data — see page
OXSQ
Oxford Square Capital Corp.
Valuation N/A
Unknown Risk 55 · Elevated
Price$1.34
Model IV—
P/IV—
Limited data — see page
OXSQG
Oxford Square Capital Corp.
Valuation N/A
Unknown Risk 51 · Elevated
Price$24.15
Model IV—
P/IV—
Limited data — see page
OXSQH
Oxford Square Capital Corp.
Valuation N/A
Unknown Risk 51 · Elevated
Price$25.10
Model IV—
P/IV—
Limited data — see page
OYSE
Oyster Enterprises II Acquisition Corp
Valuation N/A
Financial Services
Price$10.38
Model IV—
P/IV—
Limited data — see page
OYSER
Oyster Enterprises II Acquisition Corp
Valuation N/A
Financial Services
Price$0.13
Model IV—
P/IV—
Limited data — see page
OYSEU
Oyster Enterprises II Acquisition Corp
Valuation N/A
Financial Services
Price$10.66
Model IV—
P/IV—
Limited data — see page
OZK
Bank OZK
Valuation N/A
Unknown
Price$49.12
Model IV—
P/IV—
Limited data — see page
OZKAP
Bank OZK
Valuation N/A
Unknown
Price$15.50
Model IV—
P/IV—
Limited data — see page
PAAC
Proem Acquisition Corp. I
Valuation N/A
Financial Services Risk 40 · Elevated
Price$10.15
Model IV—
P/IV—
Limited data — see page
PAACU
Proem Acquisition Corp. I
Valuation N/A
Financial Services Risk 43 · Elevated
Price$10.15
Model IV—
P/IV—
Limited data — see page
PAACW
Proem Acquisition Corp. I
Valuation N/A
Financial Services Risk 53 · Elevated
Price$0.44
Model IV—
P/IV—
Limited data — see page
PAAS
PAN AMERICAN SILVER CORP
Valuation N/A
Basic Materials Risk 28 · Moderate
Price$50.34
Model IV—
P/IV—
Limited data — see page
PAC
Pacific Airport Group
Valuation N/A
Industrials
Price$202.78
Model IV—
P/IV—
Limited data — see page
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$1.30
Model IV—
P/IV—
Market implies +40.8%/yr vs model +5.2% · above model
PACH
Pioneer Acquisition I Corp
Valuation N/A
Financial Services
Price$10.33
Model IV—
P/IV—
Limited data — see page
PACHU
Pioneer Acquisition I Corp
Valuation N/A
Financial Services
Price$10.38
Model IV—
P/IV—
Limited data — see page
PACHW
Pioneer Acquisition I Corp
Valuation N/A
Financial Services
Price$0.13
Model IV—
P/IV—
Limited data — see page
PACK
Ranpak Holdings Corp.
Valuation N/A
Basic Materials Risk 53 · Elevated
Price$3.95
Model IV—
P/IV—
Market implies +17.6%/yr vs model +0.0% · above model
PAGS
PagSeguro Digital Ltd.
Valuation N/A
Technology Risk 44 · Elevated
Price$10.12
Model IV—
P/IV—
Limited data — see page
PAI
Western Asset Investment Grade Income Fund Inc.
Valuation N/A
Unknown
Price$11.66
Model IV—
P/IV—
Limited data — see page
PAII
Pyrophyte Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.30
Model IV—
P/IV—
Limited data — see page
PAL
Proficient Auto Logistics, Inc
Valuation N/A
Industrials Risk 31 · Moderate
Price$4.85
Model IV—
P/IV—
Limited data — see page
PALI
PALISADE BIO, INC.
Valuation N/A
Healthcare Risk 44 · Elevated
Price$2.06
Model IV—
P/IV—
Market implies +91.3%/yr vs model +15.0% · above model
PALO
PALOMA ACQUISITION CORP I
Valuation N/A
Financial Services
Price$9.97
Model IV—
P/IV—
Limited data — see page
PALOU
PALOMA ACQUISITION CORP I
Valuation N/A
Financial Services
Price$10.05
Model IV—
P/IV—
Limited data — see page
PALOW
PALOMA ACQUISITION CORP I
Valuation N/A
Financial Services
Price$0.32
Model IV—
P/IV—
Limited data — see page
PANL
Pangaea Logistics Solutions Ltd.
Valuation N/A
Industrials Risk 43 · Elevated
Price$8.41
Model IV—
P/IV—
Market implies -1.0%/yr vs model +2.0% · in line
PAPL
Pineapple Financial Inc.
Valuation N/A
Financial Services Risk 31 · Moderate
Price$0.95
Model IV—
P/IV—
Market implies -11.0%/yr vs model +2.0% · below model
PARK
Park Dental Partners, Inc.
Valuation N/A
Healthcare Risk 32 · Moderate
Price$21.21
Model IV—
P/IV—
Limited data — see page
PASG
Passage BIO, Inc.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$4.86
Model IV—
P/IV—
Limited data — see page
PAVM
PAVmed Inc.
Valuation N/A
Healthcare Risk 39 · Moderate
Price$4.18
Model IV—
P/IV—
Market implies +91.1%/yr vs model +2.0% · above model
PAVS
Paranovus Entertainment Technology Ltd.
Valuation N/A
Technology Risk 33 · Moderate
Price$4.50
Model IV—
P/IV—
Market implies +147.0%/yr vs model +2.0% · above model
PAX
Patria Investments Ltd
Valuation N/A
Financial Services
Price$10.62
Model IV—
P/IV—
Limited data — see page
PAXS
PIMCO Access Income Fund
Valuation N/A
Unknown
Price$13.27
Model IV—
P/IV—
Limited data — see page
PAYP
PayPay Corp
Valuation N/A
Technology Risk 58 · Elevated
Price$18.68
Model IV—
P/IV—
Limited data — see page
PBA
PEMBINA PIPELINE CORP
Valuation N/A
Energy Risk 48 · Elevated
Price$47.60
Model IV—
P/IV—
Limited data — see page
PBF
PBF Energy Inc.
Valuation N/A
Energy Risk 43 · Elevated
Price$78.30
Model IV—
P/IV—
Limited data — see page
PBM
PSYENCE BIOMEDICAL LTD.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$6.07
Model IV—
P/IV—
Limited data — see page
PBMWW
PSYENCE BIOMEDICAL LTD.
Valuation N/A
Healthcare Risk 58 · Elevated
Price$0.03
Model IV—
P/IV—
Limited data — see page
PBT
PERMIAN BASIN ROYALTY TRUST
Valuation N/A
Financial Services
Price$35.58
Model IV—
P/IV—
Limited data — see page
PC
Premium Catering (Holdings) Ltd
Valuation N/A
Consumer Cyclical Risk 38 · Moderate
Price$9.40
Model IV—
P/IV—
Market implies +42.6%/yr vs model +15.0% · above model
PCAP
ProCap Acquisition Corp
Valuation N/A
Financial Services
Price$10.37
Model IV—
P/IV—
Limited data — see page
PCAPU
ProCap Acquisition Corp
Valuation N/A
Financial Services
Price$10.45
Model IV—
P/IV—
Limited data — see page
PCAPW
ProCap Acquisition Corp
Valuation N/A
Financial Services
Price$0.30
Model IV—
P/IV—
Limited data — see page
PCF
HIGH INCOME SECURITIES FUND
Valuation N/A
Unknown
Price$5.48
Model IV—
P/IV—
Limited data — see page
PCLA
PicoCELA Inc.
Valuation N/A
Technology Risk 58 · Elevated
Price$10.11
Model IV—
P/IV—
Limited data — see page
PCM
PCM FUND, INC.
Valuation N/A
Unknown
Price$5.10
Model IV—
P/IV—
Limited data — see page
PCN
PIMCO CORPORATE & INCOME STRATEGY FUND
Valuation N/A
Unknown
Price$11.40
Model IV—
P/IV—
Limited data — see page
PCQ
PIMCO CALIFORNIA MUNICIPAL INCOME FUND
Valuation N/A
Unknown
Price$8.36
Model IV—
P/IV—
Limited data — see page
PCSA
Processa Pharmaceuticals, Inc.
Valuation N/A
Healthcare Risk 28 · Moderate
Price$1.96
Model IV—
P/IV—
Limited data — see page
PCSC
Perceptive Capital Solutions Corp
Valuation N/A
Healthcare Risk 39 · Moderate
Price$11.95
Model IV—
P/IV—
Limited data — see page
PCT
PureCycle Technologies, Inc.
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$6.02
Model IV—
P/IV—
Market implies +70.9%/yr vs model +5.0% · above model
PCTTU
PureCycle Technologies, Inc.
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$11.00
Model IV—
P/IV—
Market implies +58.2%/yr vs model +5.0% · above model
PCTTW
PureCycle Technologies, Inc.
Valuation N/A
Basic Materials Risk 40 · Elevated
Price$1.47
Model IV—
P/IV—
Market implies +40.8%/yr vs model +5.0% · above model
PCVX
Vaxcyte, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$59.54
Model IV—
P/IV—
Limited data — see page
PDC
Perpetuals.com Ltd
Valuation N/A
Technology Risk 39 · Moderate
Price$3.09
Model IV—
P/IV—
Market implies +36.2%/yr vs model +15.0% · above model
PDCC
Pearl Diver Credit Co Inc.
Valuation N/A
Unknown
Price$9.10
Model IV—
P/IV—
Limited data — see page